Patents by Inventor Taiguang Jin

Taiguang Jin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220332711
    Abstract: Novel N2-phenylpyrimidine-2,4-diamine compounds, method for preparing the same, and pharmaceutical composition or health functional food are disclosed. The novel N2-phenylpyrimidine-2,4-diamine compounds show potent inhibitory efficacies on EGFR mutations and thus, can be effectively used for the treatment of cancer with EGFR mutations.
    Type: Application
    Filed: March 31, 2022
    Publication date: October 20, 2022
    Applicant: BRIDGE BIOTHERAPEUTICS, INC.
    Inventors: Chulwon KIM, Koo LEE, GwangHee LEE, Taiguang JIN, Yong-Hee LEE, Jeong-Hyun RYOU, Jehrod BRENNEMAN, Sang Uk KANG
  • Patent number: 9458106
    Abstract: The invention provides novel compounds having the general formula: wherein R1, R2, A and W are as described herein, compositions including the compounds and methods of using the compounds.
    Type: Grant
    Filed: February 20, 2015
    Date of Patent: October 4, 2016
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Hui Hu, Min Jiang, Taiguang Jin, Rui Niu, Jianhua Wang, Min Wang, Song Yang, Taichang Yuan, Chengang Zhou, Zheng Zhou
  • Publication number: 20150158815
    Abstract: The invention provides novel compounds having the general formula: wherein R1, R2, A and W are as described herein, compositions including the compounds and methods of using the compounds.
    Type: Application
    Filed: February 20, 2015
    Publication date: June 11, 2015
    Applicant: HOFFMANN-LA ROCHE INC.
    Inventors: Hui Hu, Min Jiang, Taiguang Jin, Rui Niu, Jianhua Wang, Min Wang, Song Yang, Taichang Yuan, Chengang Zhou, Zheng Zhou